Multiplex Assay Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array)

Specificity

This assay has high sensitivity and excellent specificity for detection of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-102 99
EDTA plasma(n=5) 81-95 89
heparin plasma(n=5) 80-92 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-101% 90-99% 97-105% 79-94%
EDTA plasma(n=5) 88-95% 92-101% 80-89% 90-99%
heparin plasma(n=5) 94-101% 99-105% 97-105% 95-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clin Exp Nephrol Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173
Journal of Proteome Research Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study pubmed:28112944
OncoTargets and Therapy leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter Pubmed:29785123
PROTEOMICS – Clinical Applications Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset … Pubmed: 30411527
Cancer Management and Research iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia Pubmed: 31440093
J Clin Med A Three-Protein Panel to Support the Diagnosis of Sepsis in Children Pubmed:35329889
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPB934Mu02 Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB934Mu03 Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB934Mu01 Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
EPB934Mu61 Eukaryotic Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB934Mu01 Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB
PAB934Mu03 Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB
PAB934Mu02 Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB
SEB934Mu ELISA Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Enzyme-linked immunosorbent assay for Antigen Detection.
CMB934Mu Multiplex Assay Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMB934Mu Multiplex Assay Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.